期刊文献+

小干扰RNA沉默垂体瘤转化基因1对肝癌细胞增殖和凋亡水平的影响 被引量:4

Effect of RNA interference targeting PTTG1 gene on cell proliferation and apoptosis in hepatic cancer cells
原文传递
导出
摘要 肝癌是全世界范围的高发恶性肿瘤,在亚洲的发病率、病死率都很高。肝癌的分子学发病机制尚不完全清楚,包括基因结构和功能的缺陷、癌基因的激活、抑癌基因的失活、细胞周期紊乱、染色体的非整倍体出现以及细胞凋亡途径受阻等。垂体瘤转化基因(Frl^G)1是细胞周期调节蛋白,能抑制姐妹染色单体分离,导致染色体不稳定,形成非整倍体。
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2011年第9期703-705,共3页 Chinese Journal of Hepatology
基金 黑龙江省教育厅科学技术研究项目(1551296)
关键词 肝细胞 垂体瘤转化基因1 RNA干扰 Carcinoma, hepatocellular Pituitary tumor- transforming gene- 1 RNA interference
  • 相关文献

参考文献7

  • 1Jamagin WR. Cholangiocarcinoma of the extrahepatic bile ducts. Semin Surg Oncol, 2000, 19: 156-176.
  • 2Poon D, Anderson BO, Chen LT, et al. Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol, 2009, 10:1111-1118.
  • 3Ramaswamy S, Ross KN, Lander ES, et al. A molecular signature of metastasis in primary solid tumors. Nat Genet, 2003, 33: 49-54.
  • 4Saez C, Pereda T, Borrero JJ, et al. Expression of hpttg proto- oncogene in lymphoid neoplasias. Oncogene, 2002, 21: 8173-8177.
  • 5Tong Y, Eigler T. Transcriptional targets for pituitary tumor- transforming gene-1. J Mol Endocrinol, 2009, 43: 179-185.
  • 6Liu CL, Yu IS, Pan HW, et al. L2dtl is essential for cell survival and nuclear division in early mouse embryonic development. J Biol Chem, 2007, 282: I 109-1118.
  • 7Boelaert K, Yu R, Tannahill LA, et al. PTTG's C-terminal PXXP motifs modulate critical cellular processes in vitro. J Mol Endocrinol, 2004, 33: 663-677.

同被引文献36

  • 1Soomin Ahn,Jiyeon Hyeon,Cheol-Keun Park.Notch1 and Notch4 are markers for poor prognosis of hepatocellular carcinoma[J].Hepatobiliary & Pancreatic Diseases International,2013,12(3):286-294. 被引量:12
  • 2成夜霞,冯捷,张辛燕,付天云,姚煜.人垂体肿瘤转化基因1在卵巢癌组织中的表达及其意义[J].癌症,2004,23(9):1026-1030. 被引量:4
  • 3宗永生,吴秋良,林素暇,何洁华,张昌卿.EB病毒相关性疾病病理学研究的进展[J].中山大学学报(医学科学版),2005,26(5):481-487. 被引量:27
  • 4梁华晟,钟宇华,周少碧,梁秀就,黄宇,詹松.甲状腺肿瘤中增殖细胞核抗原和垂体肿瘤转化基因-1的表达[J].新乡医学院学报,2007,24(4):332-335. 被引量:2
  • 5Dongiovanni P, Fracanzani AL, Cairo G, et al. Iron-dependent regulation of MDM2 influences p53 activity and hepatic carcinogenesis. Am J Pathol, 2010, 176: 1006-1017.
  • 6Zhang MF, Zhang ZY, Fu J, et al. Correlation between expression of p53, p21/WAF1, and MDM2 proteins and their prognostic significance in primary hepatocellular carcinoma. J Transl Med, 2009, 7:110.
  • 7Zdzalik M, Pustelny K, Kedracka-Krok S, et al. Interaction of regulators Mdm2 and Mdmx with transcription factors p53, p63 and p73. Cell Cycle, 2010, 9: 4584-4591.
  • 8Akkiz H, Siimbiil AT, Bayram S, et al. MDM2 promoter polymorphism is associated with increased susceptibility to hepatocellular carcinoma in Turkish population. Cancer Epidemiol, 2010, 34: 448-452.
  • 9王金国,傅耀文,孙辉,等.体内TIMP-3基因电转染治疗人前列腺癌裸鼠移植瘤的研究.中国老年医学杂志,2006,26:1073-1074.
  • 10Hagymsi K, Tulassay Z. New possibilities of targeted therapy in the treatment of hepatocellular carcinoma with the help of molecular biology. Orv Hetil, 2010, 151: 1763-1768.

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部